Skip to main content

Table 4 Real value analysis of samples with substandard concentrations of the active ingredient

From: Substandard anti-malarial drugs in Burkina Faso

Active ingredient Place of purchase Real value analysis (mg) Difference
Chloroquine Phosphate (100 mg) Private pharmacy min: 89,94 10%
   max: 94,08 6%
   mid: 91,57 8%
Chloroquine Phosphate (100 mg) marked place min: 87,32 13%
   max: 91,07 9%
   mid: 88,68 11%
Chloroquine Phosphate (250 mg) marked place min: 180.16 28%
   max: 221.31 11%
   mid: 200.93 20%
Chloroquine Phosphate (250 mg) marked place min: 188,01 25%
   max: 198,67 20%
   mid: 193.34 23%
Chloroquine Phosphate (250 mg) marked place min: 188,38 25%
   max: 193,79 22%
   mid: 191.08 24%
Sulfadoxine/Pyrimethamine (500/25 mg) marked place only TLC > 20%
   performed > 20%
Quinine Sulfate (300 mg) public health facility min: 267,42 11%
   max: 291,95 3%
   mid: 277.37 7%
Quinine Sulfate (300 mg) public health facility min: 176,11 41%
   max: 286,60 4%
   mid: 237.04 21%
Quinine Sulfate (300 mg) Privat pharmacy min: 251,11 16%
   max: 276,09 8%
   mid: 266.14 11%
  1. TLC = Thin Layer Chromatography, min. = minimal detected content, max. = maximal detected content, mid. = average detected content